Cancer BiologybioRxivPreprint
AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma
Daniel Angelov, James Nolan, Gráinne Holland…·Adrian P. Bracken
This study identifies AEBP2 as a therapeutic target in EZH2-mutant lymphoma by showing its role in maintaining H3K27me2 levels through a PRC2.2 complex.